Oxford Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Oxford Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$13K	Sell	15,239 -202,329	-93%	-$235K	﹤0.01%	195
2019 Q4	$209K	Sell	217,568 -75,375	-26%	-$82.7K	0.01%	1544
2019 Q3	$302K	Sell	292,943 -52,936	-15%	-$72.1K	0.01%	1460
2019 Q2	$623K	Sell	345,879 -59,704	-15%	-$96.1K	0.01%	1180
2019 Q1	$762K	Sell	405,583 -91,615	-18%	-$134K	0.02%	1052
2018 Q4	$587K	Sell	497,198 -12,192	-2%	-$21.9K	0.02%	1126
2018 Q3	$1.33M	Buy	+509,390	New	+$1.05M	0.03%	877
2017 Q1	–	Sell	-343,172	Closed	-$463K	–	1492
2016 Q4	$463K	Buy	343,172 +133,310	+64%	+$174K	0.02%	597
2016 Q3	$327K	Sell	209,862 -561,644	-73%	-$863K	0.01%	660
2016 Q2	$1.03M	Sell	771,506 -4,730	-0.6%	-$22.1K	0.03%	480
2016 Q1	$4.09M	Sell	776,236 -186,371	-19%	-$1.14M	0.12%	209
2015 Q4	$7.55M	Buy	962,607 +949,935	+7,496%	+$8.18M	0.18%	115
2015 Q3	$107K	Sell	12,672 -697,726	-98%	-$6.44M	﹤0.01%	598
2015 Q2	$7.78M	Buy	710,398 +419,332	+144%	+$5.38M	0.21%	109
2015 Q1	$4.07M	Sell	291,066 -291,023	-50%	-$4.45M	0.1%	226
2014 Q4	$9.93M	Buy	+582,089	New	+$8.48M	0.22%	85
2013 Q4	–	Sell	-303,934	Closed	-$5.3M	–	811
2013 Q3	$5.3M	Sell	303,934 -507,397	-63%	-$9.72M	0.12%	226
2013 Q2	$13.2M	Buy	+811,331	New	+$25.1M	0.36%	47

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Oxford Asset Management's INFI Position: Q1 2020 in Review

Oxford Asset Management reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 93% in Q1 2020, selling an estimated $235K and leaving 15,239 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

Oxford Asset Management first reported a position in INFI in Q2 2013 and has held it in 18 quarters since. The position peaked at $13.2M in Q2 2013. 48 funds tracked by Wall St. Rank hold INFI as of Q1 2020.

Oxford Asset Management held 15,239 shares of Infinity Pharmaceuticals, Inc. worth $13K as of Q1 2020.
Oxford Asset Management sold 202,329 Infinity Pharmaceuticals, Inc. shares in Q1 2020, an estimated $235K.
Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Oxford Asset Management's portfolio in Q1 2020, its #195 holding.
Oxford Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 18 quarters since.
Oxford Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $13.2M in Q2 2013.
48 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.